Wiredja Online News Logo

WiredJa Online News

Wiredja Online News Logo

WiredJa Online News

JAMAICA - NHF Adds New Drugs for Arthritis and Major Depression to NHFCARD Programme

  • Written by wiredja Online News
  • Published in Health
  • 0 comments
Chief Executive Officer of the National Health Fund (NHF), Everton Anderson. Chief Executive Officer of the National Health Fund (NHF), Everton Anderson.
KINGSTON,  December 30, 2016 - Jamaica's National Health Fund (NHF) cardholders are to benefit from the addition of new drugs for the treatment of Arthritis and Major Depression.

A media release from the NHF said among the new drugs available on the health card are:Simponi Injection 50mg – 0.5mL with the active ingredient Golimumab with a subsidy of $105,896.05 per injection, Actemra Injection with active ingredient Tocilizumab with a subsidy of $27,568.00 per 200mg – 10mL injection and with a subsidy of $11,027.20 per 80mg – 4mL injection has been added for the treatment of Arthritis.

For Major Depression, Cymbalta capsules with the active ingredient Duloxetine Controlled Release with a subsidy of $124.20 per 60mg capsule and with a subsidy of $62.10 per 30mg capsule has been added.

CEO for theNational Health Fund, Mr. Everton Anderson said the addition of new drugs to the NHF card, was part of an ongoing effort by the National Health Fund to provide drugs to those in need at tremendoulsy reduced and affordable rates, in line with the government's policy of affordable health care for all its citizens.

These changes became effective December 8, 2016.

A complete drug list and subsidies paid by the National Health Fund are available from NHF participating Pharmacies, the NHF website or by calling NHF (1-888-NHF-CARE).

Last modified onFriday, 30 December 2016 19:08
  • Countries: Jamaica

Leave a comment

Make sure you enter all the required information, indicated by an asterisk (*). HTML code is not allowed.